Tumor antigen-pulsed CD8α+ dendritic cells induce T cell-mediated graft-versus-tumor effect in vitro

被引:0
|
作者
Na, Ning [2 ]
Chen, Kang [3 ]
Zhang, Jian [2 ]
He, Shanyang [4 ,5 ]
Fu, Qiang [1 ]
Zhu, Beili [6 ]
Cao, Kaiyuan [1 ]
Xu, Lin [1 ]
机构
[1] Sun Yat Sen Univ, Dept Microbiol, Zhongshan Sch Med, Guangzhou 510080, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Dept Organ Transplantat, Affiliated Hosp 3, Guangzhou 510630, Guangdong, Peoples R China
[3] Sun Yat Sen Univ, Dept Immunol, Zhongshan Sch Med, Guangzhou 510080, Guangdong, Peoples R China
[4] Sun Yat Sen Univ, Dept Obstet & Gynecol, Huangpu Hosp, Guangzhou 510700, Guangdong, Peoples R China
[5] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou 510700, Guangdong, Peoples R China
[6] Dongguan Hlth Sch, Dongguan 523000, Peoples R China
基金
中国国家自然科学基金;
关键词
dendritic cell; graft-versus-tumor; syngeneic; allogeneic; T lymphocyte; HOST-DISEASE; IMMATURE; IMMUNOTHERAPY; TOLERANCE; RESPONSES;
D O I
10.1007/s11596-011-0668-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The graft-versus-tumor (GVT) effect of T cells induced by tumor antigen-pulsed CD8 alpha(+) dendritic cells (DCs) in vitro was investigated in this study. Immature CD8 alpha(+) DCs were prepared from C57BL/6 (H-2(b)) bone marrow cells by using a cytokine cocktail. On the 3rd day of culture, CD8 alpha(+) DCs were pulsed by allogeneic (Balb/c, H-2(d)) EL9611 leukemia antigen, or RM-1 syngeneic prostate cancer antigen, with the concentration series of 0, 2.5, 5.0, 10.0, 20.0 mu g/mL, respectively, then antigen-loaded immature CD8 alpha(+) DCs were co-cultured with syngeneic T cells according to the DC/T ratio of 1:1, 2:1 and 4:1. T cell proliferation was measured by MTT assay. Cytokines including interferon gamma (IFN-gamma) and interleukin-10 (IL-10) in CD8 alpha(+) DCs and T co-culture supernatant were detected by using ELISA. Cytotoxic effect of antigen-specific T cells was tested by LDH release assay. Conventional mature DCs (mDCs) induced from C57BL/6 (H-2(b)) bone marrow cells by using granulocyte-macrophage colony stimulating factor (GM-CSF) and interleukin-4 (IL-4) served as a control. The results showed that the proliferative activity of T cells stimulated by CD8 alpha(+) DCs loaded with allogeneic or syngeneic tumor antigen was augmented with the CD8 alpha(+) DC/T ratio increased (P < 0.05). When antigen concentration a parts per thousand currency sign 5 mu g/mL and CD8 alpha(+) DC/T ratio a parts per thousand currency sign 2:1, the ability of CD8 alpha(+) DCs to stimulate T cell proliferation was higher than mDC control in allogeneic tumor antigen-pulsed groups (P < 0.05), but not in syngeneic tumor antigen-pulsed groups (P > 0.05). The level of IFN-gamma and IL-10 in CD8 alpha(+) DCs and T cell co-culture supernatant were increased in both allogeneic and syngeneic antigen-pulsed groups (P < 0.05), and the cytokine level was higher in allogeneic antigen-pulsed groups than in syngeneic antigen groups when the CD8 alpha(+) DC/T was 1:1 or 2:1 (P < 0.05). There existed a negative correlation between the level of IL-10 and T cell proliferation. T cell cytotoxicity assay showed that when CD8 alpha(+) DCs were pulsed with allogeneic tumor antigen, the maximal T cell killing efficiency could reach (100 +/- 7.7)%, whereas syngeneic tumor antigen-pulsed group had only (65.0 +/- 3.4)%. It was concluded that syngeneic and allogeneic tumor antigen-pulsed immature CD8 alpha(+) DCs could stimulate T cells to exert the GVT effect in vitro, and the GVT effect was more obvious with allogeneic tumor antigen than with syngeneic tumor antigen. The optimal condition was low allogeneic tumor antigen pulsation (a parts per thousand currency sign 5 mu g/mL) and low CD8 alpha(+) DC/T ratio (1:1 and 2:1).
引用
收藏
页码:728 / 734
页数:7
相关论文
共 50 条
  • [1] Tumor antigen-pulsed CD8α+ dendritic cells induce T cell-mediated graft-versus-tumor effect in vitro
    Ning Na
    Kang Chen
    Jian Zhang
    Shanyang He
    Qiang Fu
    Beili Zhu
    Kaiyuan Cao
    Lin Xu
    Journal of Huazhong University of Science and Technology [Medical Sciences], 2011, 31 : 728 - 734
  • [2] Tumor Antigen-pulsed CD8α~+ Dendritic Cells Induce T Cell-mediated Graft-versus-tumor Effect In Vitro
    纳宁
    陈康
    张剑
    何善阳
    傅强
    朱蓓莉
    曹开源
    徐霖
    JournalofHuazhongUniversityofScienceandTechnology(MedicalSciences), 2011, 31 (06) : 728 - 734
  • [3] The role of dendritic cells in graft-versus-tumor effect
    Toubai, Tomomi
    Mathewson, Nathan
    Reddy, Pavan
    FRONTIERS IN IMMUNOLOGY, 2014, 5
  • [4] NKT and CD8 lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigen-pulsed dendritic cells
    Shibolet, O
    Alper, R
    Zlotogarov, L
    Thalenfeld, B
    Engelhardt, D
    Rabbani, E
    Ilan, Y
    INTERNATIONAL JOURNAL OF CANCER, 2003, 106 (02) : 236 - 243
  • [5] CD103 Deficiency Prevents Graft-versus-Host Disease but Spares Graft-versus-Tumor Effects Mediated by Alloreactive CD8 T Cells
    Liu, Kechang
    Anthony, Bryan A.
    Yearsly, Martha M.
    Hamadani, Mehdi
    Gaughan, Alice
    Wang, Jiao-Jing
    Devine, Steven M.
    Hadley, Gregg A.
    PLOS ONE, 2011, 6 (07):
  • [6] Granzyme B-Mediated Damage of CD8+ T Cells Impairs Graft-versus-Tumor Effect
    Bian, Guanglin
    Ding, Xilai
    Leigh, Nicholas D.
    Tang, Youzhou
    Capitano, Maegan L.
    Qiu, Jingxin
    McCarthy, Philip L.
    Liu, Hong
    Cao, Xuefang
    JOURNAL OF IMMUNOLOGY, 2013, 190 (03): : 1341 - 1350
  • [7] A TLR5 Agonist Enhances CD8+ T Cell-Mediated Graft-versus-Tumor Effect without Exacerbating Graft-versus-Host Disease
    Ding, Xilai
    Bian, Guanglin
    Leigh, Nicholas D.
    Qiu, Jingxin
    McCarthy, Philip L.
    Liu, Hong
    Aygun-Sunar, Semra
    Burdelya, Lyudmila G.
    Gudkov, Andrei V.
    Cao, Xuefang
    JOURNAL OF IMMUNOLOGY, 2012, 189 (10): : 4719 - 4727
  • [8] Graft-versus-host disease after allogeneic hematopoietic stem cell transplantation induces a CD8+ T cell-mediated graft-versus-tumor effect that is independent of the recognition of alloantigenic tumor targets
    Stelljes, M
    Strothotte, R
    Pauels, HG
    Poremba, C
    Milse, M
    Specht, C
    Albring, J
    Bisping, G
    Scheffold, C
    Kammertoens, T
    Oelmann, E
    Silling, G
    Berdel, WE
    Kienast, J
    BLOOD, 2004, 104 (04) : 1210 - 1216
  • [9] Dendritic Cells and CD8 T Cell Immunity in Tumor Microenvironment
    Fu, Chunmei
    Jiang, Aimin
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [10] Copulsing tumor antigen-pulsed dendritic cells with zoledronate efficiently enhance the expansion of tumor antigen-specific CD8+ T cells via Vγ9γδ T cell activation
    Takahara, Masashi
    Miyai, Manami
    Tomiyama, Mai
    Mutou, Masato
    Nicol, Andrew J.
    Nieda, Mie
    JOURNAL OF LEUKOCYTE BIOLOGY, 2008, 83 (03) : 742 - 754